Moderna loses bid to shift liability in COVID-19 vaccine patent case
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Despite the backing of the U.S. government, Moderna Inc on Friday failed to persuade a federal judge it should not have to face a patent lawsuit over its COVID-19 vaccine and that the United States should have been sued instead.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1180036854-bd92321f0ee641728f625256956e8a54.jpg "Deferred Retirement Option Plans (DROPs): Everything You Need to Know")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2007594509-ba97533a0736449eb4661aa3324f7d5b.jpg "Why Should I Pay Myself First?")